ALEXANDRIA REAL EST. EQU./ US0152711091 /
2024-05-06 8:25:19 AM | Chg. +1.40 | Volume | Bid5:56:33 PM | Ask5:56:33 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
112.10EUR | +1.26% | 0 Turnover: 0.00 |
110.55Bid Size: 480 | 111.25Ask Size: 480 | 19.45 bill.EUR | - | - |
GlobeNewswire
2023-10-20
SHARC Energy at Forefront of Alexandria’s Sustainable Mega Campus Initiative
GlobeNewswire
2023-09-21
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross
GlobeNewswire
2022-02-23
Intellia Therapeutics Enters Lease Agreement to Build Manufacturing Facility for its CRISPR-based Th...
GlobeNewswire
2021-10-21
Orange Grove Bio, AlleyCorp and Alexandria Venture Investments Establish Partnership with Albert Ein...
GlobeNewswire
2021-09-21
Adaptive Biotechnologies Announces Grand Opening of State-of-the-Art Headquarters and Expands Footpr...
GlobeNewswire
2021-05-13
TCR² Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire
2021-03-29
TCR² Therapeutics Establishes Commercial-Scale Cell Therapy Manufacturing Facility
GlobeNewswire
2021-02-24
Life Science Cares and Biogen Foundation Help Launch Food For Free’s Just Eats Program
GlobeNewswire
2020-08-12
Beam Therapeutics Announces First Development Candidates for Sickle Cell Disease and Reports Second ...
GlobeNewswire
2019-11-14
Sarepta and StrideBio Announce Multi-target Strategic Collaboration to Advance Novel Gene Therapies